Response to Letter to the Editor: “High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?”
- 21 January 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 71 (1), 263-264
- https://doi.org/10.1007/s12020-020-02584-y
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?Endocrine, 2020
- Macroprolactinemia in Patients with Prolactinomas: Prevalence and Clinical SignificanceExperimental and Clinical Endocrinology & Diabetes, 2013